Cited by 890Bone Metabolism and DiseasesBone health and treatmentsBone health and osteoporosis research

The DOI matches its Crossref record; 62 of the 62 references it cites were found in a registry or an index.

Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin

Open access

Plotkin, Lilian I., Weinstein, Robert S., Parfitt, A. Michael, Roberson, Paula K., Manolagas, Stavros C., Bellido, Teresita·1999·Journal of Clinical Investigation

DOI 10.1172/jci6800PMC PMC409837

Open this paper in CoChat — free account Open PDF

Abstract

Glucocorticoid-induced osteoporosis may be due, in part, to increased apoptosis of osteocytes and osteoblasts, and bisphosphonates (BPs) are effective in the management of this condition. We have tested the hypothesis that BPs suppress apoptosis in these cell types. Etidronate, alendronate, pamidronate, olpadronate, or amino-olpadronate (IG9402, a bisphosphonate that lacks antiresorptive activity) at 10(-9) to 10(-6) M prevented apoptosis of murine osteocytic MLO-Y4 cells, whether it was induced by etoposide, TNF-alpha, or the synthetic glucocorticoid dexamethasone. BPs also inhibited apoptosis of primary murine osteoblastic cells isolated from calvaria. Similar antiapoptotic effects on MLO-Y4 and osteoblastic cells were seen with nanomolar concentrations of the peptide hormone calcitonin. The antiapoptotic effect of BPs and calcitonin was associated with a rapid increase in the phosphorylated fraction of extracellular signal regulated kinases (ERKs) and was blocked by specific inhibitors of ERK activation. Consistent with these in vitro results, alendronate abolished the increased prevalence of apoptosis in vertebral cancellous bone osteocytes and osteoblasts that follows prednisolone administration to mice. These results suggest that the therapeutic efficacy of BPs or calcitonin in diseases such as glucocorticoid-induced osteoporosis may be due, in part, to their ability to prevent osteocyte and osteoblast apoptosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1172/jci6800

Cites

62 of 62 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Caspases: Enemies Within
Thornberry, N. A., & Lazebnik, Y. A. (1998) · Science · doi:10.1126/science.281.5381.1312 · Cited by 6,857
Death Receptors: Signaling and Modulation
Ashkenazi, A., & Dixit, V. M. (1998) · Science · doi:10.1126/science.281.5381.1305 · Cited by 5,866
Opposing Effects of ERK and JNK-p38 MAP Kinases on Apoptosis
Xia, Z., Dickens, M., Raingeaud, J., Davis, R. J., & Greenberg, M. E. (1995) · Science · doi:10.1126/science.270.5240.1326 · Cited by 5,273
PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in Vivo
Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T., & Saltiel, A. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27489 · Cited by 3,374
Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase
Favata, M. F., Horiuchi, K. Y., Manos, E. J., Daulerio, A. J., Stradley, D. A., Feeser, W. S., Dyk, D. E. V., Pitts, W. J., Earl, R. A., Hobbs, F. W., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18623 · Cited by 3,016
The Fire of Life: An Introduction to Animal Energetics
Kleiber, M. (1975) · Medical Entomology and Zoology · Cited by 2,529
A short amino acid sequence able to specify nuclear location
Kalderon, D., Roberts, B., Richardson, W. D., & Smith, A. E. (1984) · Cell · doi:10.1016/0092-8674(84)90457-4 · Cited by 2,511
Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone.
Weinstein, R. S., Jilka, R. L., Parfitt, A. M., & Manolagas, S. C. (1998) · Journal of Clinical Investigation · doi:10.1172/jci2799 · Cited by 1,753 · cited 12×
“The TUNEL reaction was performed according to the manufacturer’s instructions, using 0.15% CuSO4 for color enhancement.”
BackgroundMethodResultInfluentialSelf-citation
Nitrogen-Containing Bisphosphonates Inhibit the Mevalonate Pathway and Prevent Post-Translational Prenylation of GTP-Binding Proteins, Including Ras
Luckman, S. P., Hughes, D. E., Coxon, F. P., Russell, R. G. G., & Rogers, M. J. (1998) · Journal of Bone and Mineral Research · doi:10.1359/jbmr.1998.13.4.581 · Cited by 1,176
DNA binding of the glucocorticoid receptor is not essential for survival
Reichardt, H. M., Kaestner, K. H., Tuckermann, J., Kretz, O., Wessely, O., Bock, R., Gass, P., Schmid, W., Herrlich, P., Angel, P., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81183-6 · Cited by 1,068

Flagged first, then by citations

Show all 62 references

Research works printed but not linked: 8

Cummings, 1996, J Bone Miner Res, 11(Suppl.), S102
Marotti, 1990, Ital J Miner Electrol Metab, 4, 93
Dennison, 1999, Osteoporos Int, 9, S16
Weinstein, 1998, Bone, 23(Suppl), S461
Falcini, 1996, Calcif Tissue Int, 58, 166
Grignani, 1998, Cancer Res, 58, 14
Giuliani, 1995, J Bone Miner Res, 10(Suppl), S171
Marotti, 1996, Ital J Anat Embryol, 101, 25

Sorted by citations

Items 701–800 of 888

Osteonecrosis. What Is New?
Martínez-Ferrer, M. Á., Peris, P., & Guañabens, N. (2007) · Reumatología Clínica (English Edition) · doi:10.1016/s2173-5743(07)70216-2 · Cited by 3
Rheumatic diseases, glucocorticoid treatment and bone mass: Recent developments
Mazzantini, M., & Lane, N. E. (2000) · Clinical and Experimental Rheumatology · Cited by 3
Bone Effects of Glucocorticoid Therapy
Väänänen, K., & Härkönen, P. L. (2002) · Springer eBooks · doi:10.1007/978-3-662-04660-9_4 · Cited by 3
Single-cell Transcriptome Analysis Identifies Senescent Osteocytes as Contributors to Bone Destruction in Breast Cancer MetastasisPreprint
Delgado‐Calle, J., Adhikari, M., Kaur, J., Sabol, H. M., Anloague, A., Khan, S., Kurihara, N., Diaz‐delCastillo, M., Andreasen, C. M., Barnes, C. L., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-4047486/v1 · Cited by 3
Comparative Bone-Protective Effects of Tocotrienol Isomers from Palm and Annatto in Dexamethasone-Induced Osteoporotic Male Rats
Ramli, E. S. M., Ahmad, F., Kamaruddin, N. A., Chin, K., Soelaiman, I. N., & Pang, K.-L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262010206 · Cited by 2
Ostéoradionécrose et ostéonécrose des maxillaires aux bisphosphonates
Salino, S., Bodard, A., & Timour, Q. (2010) · Cited by 2
Identification of hub genes and therapeutic drugs in osteonecrosis of the femoral head through integrated bioinformatics analysis and literature mining
Tang, L. F., Li, B., Su, Q., Chen, X., & He, R. (2023) · Scientific Reports · doi:10.1038/s41598-023-39258-4 · Cited by 2
Comparison of the prophylactic use of ibandronate and its use in early-stage osteonecrosis in rats with steroid-induced osteonecrosis of the femoral head
Çağlar, S., Daşcı, M. F., Acar, A., Çağlar, A., Dinçel, Y. M., & Çataltepe, A. (2023) · Joint Diseases and Related Surgery · doi:10.52312/jdrs.2023.1096 · Cited by 2
Bisphosphonatassoziierte Nekrosen der Kiefer
Hermes, D., Beier, P., & Peters, K. (2008) · Der Onkologe · doi:10.1007/s00761-008-1421-2 · Cited by 2
Calcitonin Functions Both as a Hypocalcemic Hormone and Stimulator of Steroid Production and Oocyte Maturation in Ovarian Follicles of Common Carp, Cyprinus carpio
Mukherjee, D., Kundu, S., Pramanick, K., Paul, S., & Mallick, B. (2011) · InTech eBooks · doi:10.5772/17291 · Cited by 2
Hypercalcémie de l'adulte
Vieillard, M.-H., Gerot-Legroux, I., & Cortet, B. (2009) · EMC - Appareil locomoteur · doi:10.1016/s0246-0521(09)44926-x · Cited by 3
Bisphosphonates and BMU birth rate: response to comments by Ott
Seeman, E. (2009) · Osteoporosis International · doi:10.1007/s00198-009-1027-6 · Cited by 2
Differential Response of Risedronate on Tibial and Mandibular Bone Quality in Glucocorticoid-treated Growing Rats
Fujita, Y. (2008) · The Journal of the Kyushu Dental Society · doi:10.2504/kds.62.1 · Cited by 2
Glucocorticosteroid-induced osteoporosis: pathogenesis, prevention, treatment
Baranova, I. A., & Baranova, I. A. (2008) · Modern Rheumatology Journal · doi:10.14412/1996-7012-2008-455 · Cited by 3
Why to Keep Osteocytes Alive and How?
Bellido, T. (2009) · Journal of Korean Endocrine Society · doi:10.3803/jkes.2009.24.4.223 · Cited by 2
Self-citation
Defining the role of bisphosphonates for osteonecrosis of the knee: a systematic review
Jordan, R. W., Jones, A. D. R., & Pearse, A. J. (2016) · Current Orthopaedic Practice · doi:10.1097/bco.0000000000000367 · Cited by 2
Calcitonin
Findlay, D. M., Sexton, P. M., & Martin, T. J. (2016) · Endocrinology: Adult and Pediatric · doi:10.1016/b978-0-323-18907-1.00058-5 · Cited by 2
Osteoblast Biology
Lian, J. B., & Stein, G. S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-375098-3.50007-x · Cited by 2
Bisphosphonates: from bone anti-resorptive to anti-cancer drugs.
Shalayel, M. H. F., Alsareii, S. A., Elbashir, A. M., & Huneif, M. A. (2017) · doi:10.35841/medical-oncology.2.1.20-23 · Cited by 2
Mechanistic and Clinical Studies of Platelet Rich Plasma: A Simple Clinical Method for Enhancing Bone and Soft Tissue Healing
Rutkowski, J. L. (2008) · Cited by 2
Histomorphometry of Metabolic Bone Conditions
Hauge, E., Steiniche, T., & Andreassen, T. T. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-417-7_29 · Cited by 2
Manipulating Programmed Cell Death for Better Living! Review and commentary on Apoptosis in Health and Disease , edited by Robert R. Ruffolo, Jr. and Frank Walsh, Harwood Academic Publishers, Amsterdam, Netherlands, 2000, 249 pp. $80.00, ISBN: 90-5823-086-4
Manolagas, S. C. (2001) · Science s STKE · doi:10.1126/stke.2001.87.pe1 · Cited by 2
Self-citation
Biologia da movimentação dentária induzida e das reabsorções radiculares associadas: influência do gênero e dos bisfosfonatos
Santamaria, M. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.25.2009.tde-30062009-163844 · Cited by 2
Acid-base Balance and Oxidative Metabolism in Calcified Tissues
Riihonen, R. (2010) · UTUPub (University of Turku) · Cited by 2
INTRAVENOUS ZOLEDRONIC ACID IN POSTMENOPAUSAL WOMEN WITH LOW BONE MINERAL DENSITY
Эйд, Р., Acques, J., Rown, P. B., Urckhardt, P. E. B., Orowitz, H., Ichardson, P. E. R., Ean, J., Aufman, A. K., Aeger, P. H. J., Ody, B., et al. (2002) · Cited by 2
The Molecular Pharmacology of Osteoporosis
Iqbal, J. Z., Inzerillo, A. M., Moonga, B. S., & Zaidi, M. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-278-4_28 · Cited by 2
Therapeutic perspectives of exosomes in glucocorticoid-induced osteoarthrosis
Lv, B., Cheng, Z., Yu, Y., Chen, Y., Gan, W., Li, S., Zhao, K., Cao, Y., & Zhang, Y. (2022) · Frontiers in Surgery · doi:10.3389/fsurg.2022.836367 · Cited by 2
Role of Cx43 on the Bone Cell Generation, Function, and Survival
Plotkin, L. I., Asad, I., Kritikos, A. E., & Sanz, N. (2023) · Bioelectricity · doi:10.1089/bioe.2023.0028 · Cited by 1
Self-citation
Bridging Biochemistry and Aging: A Journey Towards Prolonged Health span
Panchal, N. (2024) · Biosciences Biotechnology Research Asia · doi:10.13005/bbra/3226 · Cited by 1
Inhibition of osteocyte apoptosis does not prevent iron overload-induced bone resorption and bone loss
Guo, Z., Hu, Y., Zhou, J., Zhang, Y., Zhang, J., Yang, L., Wang, S., Wu, J., & Yang, J. (2024) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2024.151152 · Cited by 2
Capsaicin counteracts dexamethasone-induced osteoporosis and metabolic disturbances in rats: role of AMPK/SIRT1/β-catenin/RUNX2 pathway
Habiba, E. S., Fathelbab, M. H., Omar, E. M., El-Alkamy, A., Omar, W. E., & Harby, S. A. (2025) · Journal of Molecular Histology · doi:10.1007/s10735-025-10460-0 · Cited by 1
Structural and energetic effects of disulfide mediation on the conformational dynamics of human calcitonin
Huang, F., Zhang, Y., Zhang, X., Xu, J., Wang, C., Huang, X., Liu, S., Ding, F., & Sun, Y. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.149880 · Cited by 1
Nutraceuticals in orthopedic implant osseointegration: Mechanisms, evidence, and clinical perspectives
Ricciardi, G., Donadio, D., Ficarra, G., Nasso, C., Foglia, P., Bitto, A., Scarfì, R., Fadda, G., Corpina, F., Cutè, E., et al. (2026) · Bone · doi:10.1016/j.bone.2026.117801 · Cited by 1
CORTICOSTEROID USE IN SYSTEMIC LUPUS ERYTHEMATOSUS
Shanahan, J. C., & Kimberly, R. P. (2004) · Elsevier eBooks · doi:10.1016/b9-78-012433-9/01950-0491 · Cited by 1
Bisphosphonates and Bone Microdamage
Caruthers, W. A. (2012) · UKnowledge (University of Kentucky) · Cited by 1
Lessons from Glucocorticoid Receptor Action in Bone: New Ways to Avoid Side Effects of Steroid Therapy
Rauch, A., Baschant, U., & Tuckermann, J. P. (2012) · Springer eBooks · doi:10.1007/978-1-4614-5366-6_5 · Cited by 1
Osteoconductive action of alendronate after implantation of beta tricalcium phosphate in rat adjuvant-induced arthritis
Netsu, T., Kondo, N., Arai, K., Ogose, A., & Endo, N. (2012) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-012-0369-x · Cited by 1
Documenting the Use of Calcium Supplements with Oral Bisphosphonates
Nye, A. M., Hamrick, I., Rauch, A., Pound, M. W., & Shelton, P. S. (2013) · The Consultant Pharmacist · doi:10.4140/tcp.n.2013.31 · Cited by 1
Basic Aspects of Calcitonin in Skeletal Health
Gennari, C. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-278-4_20 · Cited by 1
Uso do pamidronato na síndrome SAPHO
Machado, L. G., Capp, A. A., Paes, M. A. D. S., de Oliveira, R. B., & Bonfante, H. D. L. (2005) · Revista Brasileira de Reumatologia · doi:10.1590/s0482-50042005000600013 · Cited by 1
Inhibition by minodronate of basic fibroblast growth factor-stimulated vascular endothelial growth factor synthesis in osteoblast-like cells
Tokuda (2009) · Molecular Medicine Reports · doi:10.3892/mmr_00000235 · Cited by 1
Tartrate-resistant acid phosphatase: three-dimensional structure and structure-based functional studies : studies on the enzyme using recombinant protein produced by baculovirus expression vector system in insect cells
Kaija, H. (2002) · Cited by 1
Treatment and Prevention of Glucocorticoid-Induced Osteoporosis
Micheletti, R. G., Murrell, D. F., & Werth, V. P. (2015) · Springer eBooks · doi:10.1007/978-3-662-45698-9_63 · Cited by 2
Clinical Utilization of Salmon Calcitonin in the Treatment of Osteoporosis
Chesnut, C. H., & Azria, M. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-278-4_21 · Cited by 1
Response of trabecular bone, thyroid C and follicular cells to synthetic salmon calcitonin in middle‐aged orchidectomized male rats
Filipović, B. R., Šošić‐Jurjević, B., Ajdžanović, V. Z., Živanović, J., Ristić, N., Trifunović, S. L., & Milošević, V. (2017) · Journal of Anatomy · doi:10.1111/joa.12600 · Cited by 1
Mining and analysis of adverse event signals for alendronate based on the real-world data of FDA adverse event reporting system database
Zhao, Z., Ji, H., Zhang, C., Wang, Z., Ren, S., Liu, C., Wu, C., Wang, J., & Ding, X. (2024) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2024.2419995 · Cited by 1
Bisphosphonates in Pediatric Burn Injury
Klein, G. L. (2014) · Springer eBooks · doi:10.1007/978-1-4899-7436-5_7 · Cited by 1
Bone Morphogenic Proteins, Osteoblast Differentiation, and Cell Survival During Osteogenesis
Wang, C. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-736-9_13 · Cited by 1
The Molecular Biology of Sex Steroids in Bone
Kousteni, S. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374602-3.00022-5 · Cited by 1
Bisphosphonates Zoledronate and Alendronate for the Management of Postmenopausal Osteoporosis
Radwan, I. A., Korany, N. S., & Ezzat, B. A. (2018) · Case Reports in Clinical Medicine · doi:10.4236/crcm.2018.75030 · Cited by 1
Basic and clinical aspects of glucocorticoid action in bone
Zhou, H., Cooper, M. S., & Seibel, M. J. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-814841-9.00039-7 · Cited by 1
Osteocyte Mechanobiology in Aging and Disease
Donahue, H. J., Friendman, M. J., & Genetos, D. C. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-817931-4.00001-7 · Cited by 1
Calcitonin
Martin, T. J., Findlay, D. M., & Sexton, P. M. (2010) · Elsevier eBooks · doi:10.1016/b978-1-4160-5583-9.00057-5 · Cited by 1
Glucocorticoid-induced Osteoporosis: From Pathogenesis to Treatment
Chung, Y. (2009) · Cited by 1
Effects of chemotherapy-induced ovarian failure on bone and lipid metabolism in premenopausal breast cancer patients : Impact of adjuvant clodronate and tamoxifen
Vehmanen, L. (2005) · Työväentutkimus Vuosikirja · Cited by 1
Desarrollo y caracterización de matrices compuestas quitosano/polímero sintético para regeneración de tejido óseo
Berghoff, C. F. (2011) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/2769 · Cited by 1
Aspectos genéticos, influência do eixo GH/IGF1 e novas possibilidades terapêuticas na osteoporose idiopática
Lopes, R. F., & Farias, M. L. F. (2006) · Revista Brasileira de Reumatologia · doi:10.1590/s0482-50042006000200005 · Cited by 1
Comment on Osteocytes: Masters Orchestrators of Bone
Plotkin, L. I., & Bellido, T. (2014) · Calcified Tissue International · doi:10.1007/s00223-014-9905-0 · Cited by 1
Self-citation
Evidences of safety and tolerability of the zoledronic acid 5 mg yearly in the post-menopausal osteoporosis: the HORIZON project
Carbonare, L. D., Bertoldo, F., & Cascio, V. L. (2011) · Reumatismo · doi:10.4081/reumatismo.2009.54 · Cited by 1
Therapeutic patenting for glucocorticoid-induced osteoporosis
Cooper, M. S., & Stewart, P. M. (2000) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.10.6.847 · Cited by 1
New insights into the mechanisms of bisphosphonates action
Tsetsenekou, E., & Kalyvas, D. (2010) · Cited by 1
Connexin-Mediated Signaling in Bone
Plotkin, L. I., & Bonetto, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.11213-9 · Cited by 1
Self-citation
Partial prevention of glucocorticoid-induced osteocyte deterioration with osteocrin gene therapyPreprint
Mazur, C. M., Castro, C. D., Sato, T., Bruce, M., Bouxsein, M., Wang, J. S., & Wein, M. N. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.11.19.469265 · Cited by 1
Skeletal Complications of Malignancy: Central Role for the Osteoclast
Clines, G. A., Chirgwin, J. M., & Guise, T. A. (2005) · Springer eBooks · doi:10.1007/1-84628-016-8_9 · Cited by 1
Endogenous Osteocyte-Osteoclast Signaling Enables Bone Remodeling, Drug Response, and Cancer Invasion in a Nanoscale Calcified Bone-on-a-Chip ModelPreprint
Sousa, M. G. D. C., Athirasala, A., Roth, D. M., Hosseini, M., Romanowicz, G. E., Duhen, R., Fraga, M. A. A., Vignolo, S. M., Doe, A. R., Lee, J., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.08.693047 · Cited by 1
Fisiología del hueso y marcadores bioquímicos del recambio óseo
Canelas, A. C., Cenarruzabeitia, N. V., & Corrales, E. P. (2014) · Elsevier eBooks · doi:10.1016/b978-84-9022-503-5.00002-2 · Cited by 1
Bedeutung von RANK-Ligand und Osteoprotegerin für den Knochenstoffwechsel
Hofbauer, L. C., & Schoppet, M. (2006) · Springer eBooks · doi:10.1007/3-540-28782-5_21
An Agent-based Model for Evaluating Cellular Mechanisms of Bone Remodeling
Schutte, L. (2012) · KiltHub Repository · doi:10.1184/r1/6714668
Androgen Action in Bone
Wiren, K. M. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-278-4_17
Microdamage: Its Role in the Mechanical Integrity of Low Bone Mass Diseases and its Treatment Implications.
Davis, M. S. (2013) · Deep Blue (University of Michigan)
Wirkungsweise von Bisphosphonaten auf die Expression verschiedener Knochenmarker in mesenchymalen Stammzellen der Plazenta
Kemper, G. (2010) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-857
Auswirkung von Bisphosphonaten auf die Expression von Osteoprotegerin (OPG) und Receptor activator of nuclear factor êB ligand (RANKL) in Osteoblastenkulturen aus Unterkiefer und Becken - Eine Pilotstudie am Hausschwein
Sievers, N. (2012) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-1628
Cholesterol, Interleukin‒6 Inflammation, and Atherosclerosis—Role of Statins, Bisphosphonates, and Plant Polyphenols in Atherosclerosis and Other Diseases of Aging
Omoigui, S. (2007) · Wiley eBooks · doi:10.1002/9780470692325.ch23
Estudio experimental de la regeneración de defectos óseos en cúbitos de conejos de Nueva Zelanda albinos, inducida por la aplicación tópica de aledronato de sodio gelificado y/o beta fosfato tricálcico
Blanco-Antona, L. A. (2013) · Gredos (University of Salamanca) · doi:10.14201/gredos.124078
Bone metabolism and inflammatory bowel disease
Abreu, M. T. (2007) · Springer eBooks · doi:10.1007/0-387-25808-6_49
Efectos de los productos de glicación avanzada (AGEs) y la metformina sobre el hueso; estudios in vitro e in vivo
Arnol, V. (2012) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/2765
Kieferosteonekrose unter antiosteoklastischer Therapie
Adamietz, I. A., & Kunkel, M. (2013) · Der Onkologe · doi:10.1007/s00761-013-2438-8
Differentiation of osteoblasts to osteocytes in 3D type I collagen gels - a novel tool to study osteocyte responses to mechanical loading
Scully, N. E. E. (2015) · ORCA Online Research @Cardiff (Cardiff University)
Development of a Bisphosphonate Delivering Hydrogel for the Augmentation of Impaired Peri-Implant Bone
Kettenberger, U. (2014) · Infoscience (Ecole Polytechnique Fédérale de Lausanne) · doi:10.5075/epfl-thesis-6370
Efecto de AGEs (productos de glicación avanzada) y drogas anti-resortivas sobre células de hueso en cultivo
Gangoiti, M. V. (2011) · El Servicio de Difusión de la Creación Intelectual (National University of La Plata) · doi:10.35537/10915/2688
Problèmes méthodologiques de la mesure de densité osseuse par absorptiométrie biphotonique
Roux, C., & Dougados, M. (2001) · ITBM-RBM · doi:10.1016/s1297-9562(01)90032-4
Potential of calcitonin as a novel cotreatment for arthritis
Perretti, M., & Mancini, L. (2007) · Future Rheumatology · doi:10.2217/17460816.2.5.493
Traitement médicamenteux des ostéoporoses post-ménopausiques et cortisoniques
Roux, C. (2002) · Revue du Rhumatisme · doi:10.1016/s1169-8330(02)00426-x
Prise en charge de l'ostéoporose cortisonique en 2005
Orcel, P. (2005) · Revue du Rhumatisme · doi:10.1016/j.rhum.2005.09.007
Ostéoporose cortico-induite : données physiopathologiques et thérapeutiques récentes
Lafage‐Proust, M., Boudignon, B. M., & Thomas, T. (2003) · Revue du Rhumatisme · doi:10.1016/s1169-8330(03)00059-0
Pharmacotherapy of osteoporosis.
Koida, M. (2002) · Folia Pharmacologica Japonica · doi:10.1254/fpj.120.379
Hipercalcemia del adulto
Vieillard, M.-H., Gerot-Legroux, I., & Cortet, B. (2009) · EMC - Aparato Locomotor · doi:10.1016/s1286-935x(09)70888-3
Developing a Research Agenda in Biogerontology: Physiological Systems
Carrington, J. L., & Bellino, F. L. (2006) · Science of Aging Knowledge Environment · doi:10.1126/sageke.2006.10.pe17
La situación actual de la utilización de la calcitonina en la osteopenia/osteoporosis
Carranza, F. H. (2001) · Revista Clínica Española · doi:10.1016/s0014-2565(01)70881-8
EFFECTS OF PHYSICAL EXERCISE ON FEMORAL BONE MINERAL DENSITY AND OSTEOCYTE MICROMORPHOLOGY IN YOUNG OVARIECTOMIZED (OVX) RATS
Kawakami, T., Takise, S., & KAWATA, H. (2010) · 体力科學 · doi:10.7600/jspfsm.59.395
Sequential treatment with monofluorophosphate and zoledronic acid in osteoporotic rats
Brance, M. L., Brun, L. R., Loreto, V. E. D., Lupo, M., & Rigalli, A. (2013) · Climacteric · doi:10.3109/13697137.2013.860117
How do antiresorptive agents reduce fracture risk?
Seeman, E. (2001) · BoneKEy-Osteovision · doi:10.1138/2001012
Effect of systemic glucocorticoid therapy on bone metabolism: an update
Cooper, M. S. (2006) · Expert Review of Endocrinology & Metabolism · doi:10.1586/17446651.1.1.111
Disorders of endocrine, reproductive and skeletal systems following allogeneic or autologous stem cell transplantation for hematological malignancies in adults
Tauchmanovà, L. (2006) · Università degli Studi di Napoli Federico II · doi:10.6092/unina/fedoa/794
La calcitonina hoy
Lenza, H. R. (2003) · Revista Clínica Española · doi:10.1016/s0014-2565(03)71215-6
The art of treating osteoporosis: Bisphosphonates
Мазуренко, С. О. (2012) · Modern Rheumatology Journal · doi:10.14412/1996-7012-2012-716
Effects of Chemotherapy on Bone Growth and Chondrocyte Cell Death Signaling
Zaman, F. (2010) · Figshare
ALENDRONATE A PROMISING / MULTI ASPECT DRUG IN THE MANAGEMENT OF OSTOEOPOROSIS
Shaheen, S., Barakzai, Q., Noor, S. S., Khan, M. A., & Karachi, C. (2011)
Salmon Calcitonin in the Treatment of Osteopor osis
Goel, A. K. (2010)
Etude de la densité minérale osseuse par absorptiomètre biphotonique chez les asthmatiques sous corticoïdes inhales
Sadni, S. (2008)

Authors: Plotkin, L. I., Weinstein, R. S., Parfitt, A. M., Roberson, P. K., Manolagas, S. C., & Bellido, T.
Affiliations: University of Arkansas for Medical Sciences (US)
Central Arkansas Veterans Healthcare System (US)
Corresponding author: Bellido, Teresita
ORCID: Plotkin, Lilian I.
Weinstein, Robert S.
Roberson, Paula K.
Manolagas, Stavros C.
Bellido, Teresita
Venue: Journal of Clinical Investigation
Publisher: American Society for Clinical Investigation
Published: 1999-11-15
Volume: 104
Issue: 10
Pages: 1363-1374
ISSN: 0021-9738 (ISSN-L)
DOI: 10.1172/jci6800
PMC: PMC409837
OpenAlex: W2170680219
Cited by: 890
References: 62
Citations by year: 2026: 5 · 2025: 8 · 2024: 11 · 2023: 13 · 2022: 19 · 2021: 15 · 2020: 21 · 2019: 24 · 2018: 24 · 2017: 29 · 2016: 41 · 2015: 26 · 2014: 54 · 2013: 44 · 2012: 40
FWCI: 11.43
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Journal of Clinical Investigation (publishedVersion)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health (5r01ar043003-05)
National Institute on Aging (P01AG/AMS13918, P01AG013918)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 AR43003, R01AR046191)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
Health Sciences › Medicine › Oncology › Bone health and treatments
Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Keywords: bisphosphonates, calcitonin, osteocyte apoptosis, osteoblast apoptosis, glucocorticoid-induced osteoporosis, alendronate, etidronate, pamidronate, extracellular signal-regulated kinase, ERK1/2 phosphorylation, dexamethasone, TNF-α, etoposide, prednisolone, MLO-Y4 cells, trabecular bone
MeSH terms: Pamidronate, Animals, Calcitonin, Cell Line, Cells, Cultured, Dexamethasone, Diphosphonates, Etoposide, Osteoblasts, Osteocytes, Prednisolone, Skull, Etidronic Acid, Tumor Necrosis Factor-alpha, Apoptosis, Alendronate, In Situ Nick-End Labeling, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks